PubRank

M Hebbar

Author PubWeight™ 29.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000 1.45
2 [Dermatopolymyositis and chronic lymphoid leukemia. Apropos of 2 cases]. Rev Med Interne 1993 1.39
3 Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res 1998 1.32
4 Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993 1.29
5 Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score. Aliment Pharmacol Ther 2011 1.17
6 Laparoscopic resection vs. open liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: a case-matched study. Surg Endosc 2011 1.16
7 The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family. Oncogene 2012 1.11
8 Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 2005 1.09
9 Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Res 2001 1.05
10 'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'. Br J Cancer 2006 0.99
11 Basic fibroblast growth factor receptors and their prognostic value in human breast cancer. Clin Cancer Res 1998 0.98
12 Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection. Eur J Surg Oncol 2012 0.94
13 Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer. Br J Cancer 2009 0.94
14 Prognostic factors in myelodysplastic syndromes: critical analysis of the impact of age and gender and failure to identify a very-low-risk group using standard mortality ratio techniques. Br J Haematol 1996 0.92
15 Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study. Ann Oncol 2006 0.91
16 Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6. Oncology 2011 0.89
17 Relationship between parity and clinical and biological features in patients with systemic sclerosis. J Rheumatol 2001 0.86
18 Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 2004 0.85
19 Docetaxel therapy for advanced hepatocellular carcinoma developed in healthy liver: report of three cases. J Chemother 2008 0.83
20 Age as a prognostic factor in breast cancer. Anticancer Res 1998 0.82
21 [Pulmonary hypertension screening in systemic scleroderma: a cohort study of 67 patients]. Rev Med Interne 2001 0.82
22 [Systemic scleroderma and cancer. Search for predictive factors of cancer in 123 patients with scleroderma]. Rev Med Interne 1997 0.81
23 [Acute pancreatitis, systemic lupus and antiphospholipid syndrome. 2 cases]. Rev Med Interne 1994 0.80
24 [Yellow nail syndrome associated with rheumatoid arthritis. Regression under chrysotherapy]. Rev Med Interne 1997 0.79
25 [Wegener's granulomatosis in the elderly patient]. Rev Med Interne 2001 0.79
26 Regulation of sialyltransferase expression by estradiol and 4-OH-tamoxifen in the human breast cancer cell MCF-7. Mol Cell Biol Res Commun 2000 0.79
27 [Standards, Options and Recommendations 2004: good practice guidelines for second opinion in anatomic and surgical pathology in oncology (integral report)]. Bull Cancer 2004 0.78
28 Plasma c-erbB2 concentrations in relation to chemotherapy in breast cancer patients. Eur J Cancer 1996 0.77
29 De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features? Leuk Res 1993 0.76
30 Aerosolized iloprost in CREST syndrome related pulmonary hypertension. J Rheumatol 2001 0.76
31 A phase II trial of raltitrexed (Tomudex) in advanced pancreatic and biliary carcinoma. Oncology 2005 0.75
32 Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal Cancer. J Oncol 2010 0.75
33 Long-term survivors in myelodysplastic syndromes: a report on 63 cases and comparison with short and intermediate survivors. Leuk Res 1993 0.75
34 FOLFIRI chemotherapy in patients with advanced non resectable esophageal or junctional adenocarcinoma: a pilot study. J Chemother 2011 0.75
35 [Systemic sclerosis and pregnancy]. Rev Med Interne 2002 0.75
36 Glutathione S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens. Leukemia 1997 0.75
37 [Bronchiolitis obliterans with organized pneumonia: a rare complication of primary Gougerot-Sjögren syndrome]. Rev Med Interne 2000 0.75
38 [A rugbyman and four bats]. Rev Med Interne 2000 0.75
39 [Gallium scintigraphy disclosing tumor of the small intestine!]. Rev Med Interne 1997 0.75
40 [Primary biliary cirrhosis and systemic scleroderma (Reynolds syndrome): apropos of 8 new cases. The contribution of accessory salivary gland biopsy]. Rev Med Interne 1998 0.75
41 [Pancreatic tuberculosis in systemic lupus]. Presse Med 1994 0.75
42 [Efficacy of methylprednisolone embolus on the auditory involvement of Cogan syndrome]. Presse Med 1989 0.75
43 [Meningoradiculitis in systemic lupus: role of antiphospholipid antibodies?]. Rev Med Interne 1996 0.75
44 [Psychiatric complications of corticoid therapy in the elderly over 65 years of age treated for Horton disease]. Rev Med Interne 2002 0.75
45 Distribution and prognostic value of the fibroblast growth factor-2 low-affinity binding sites in human breast cancer. Anticancer Res 2001 0.75
46 [Influence of age on the clinical and biological characteristics of systemic scleroderma]. Rev Med Interne 1999 0.75
47 The role of intensive chemotherapy in myelodysplastic syndromes. Leuk Lymphoma 1992 0.75
48 [After winter ... springtime]. Rev Med Interne 1997 0.75